Product Code: ETC6185521 | Publication Date: Sep 2024 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
Australia`s molecular imaging market is growing due to advancements in diagnostic imaging technologies, a rising aging population, and increased cancer and cardiovascular disease prevalence. PET, SPECT, and hybrid imaging systems are central to this market, providing real-time insights at the molecular level. Research institutions and hospitals are major consumers, supported by government investments in medical infrastructure and innovation.
Australias molecular imaging market is benefiting from growing investments in precision medicine and cancer diagnostics. PET and SPECT imaging technologies are witnessing enhanced adoption in oncology, cardiology, and neurology, driven by improved radiotracers and hybrid imaging systems like PET/CT and SPECT/CT. The expansion of nuclear medicine facilities and government support for diagnostic imaging infrastructure is further accelerating market growth. AI-powered image analysis and 3D reconstruction are also emerging as crucial value additions.
The molecular imaging market in Australia faces challenges primarily in terms of high equipment costs and limited reimbursement policies. Smaller healthcare providers often struggle with the financial feasibility of adopting advanced imaging technologies. There is also a shortage of skilled professionals capable of interpreting molecular imaging data accurately. Additionally, the slow pace of clinical adoption due to regulatory hurdles and lack of awareness about the benefits of molecular imaging contributes to restrained market growth.
Investing in the molecular imaging market in Australia presents opportunities in both diagnostic imaging and research. The growing demand for precision medicine and the development of advanced imaging technologies such as PET, SPECT, and MRI systems offers substantial returns. Investors can target companies advancing hybrid imaging systems or those developing radiotracers for oncology, cardiology, and neurology. Furthermore, the expansion of nuclear medicine facilities and government support for diagnostic imaging infrastructure provides a stable investment environment. Additionally, the integration of AI in molecular imaging to improve diagnostic accuracy offers exciting investment potential in technology-driven innovations.
Molecular imaging technologies are regulated by the Therapeutic Goods Administration (TGA) under the Therapeutic Goods Act, with strict requirements for the approval of radiopharmaceuticals and imaging devices. These policies ensure patient safety but often delay market entry for novel imaging technologies. Additionally, Medicare reimbursement policies for diagnostic imaging can be restrictive, limiting the commercial viability of some advanced techniques. Despite this, the government is increasing funding for nuclear medicine, which may support the market in the long term, albeit at a slow pace.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Molecular Imaging Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Molecular Imaging Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Molecular Imaging Market - Industry Life Cycle |
3.4 Australia Molecular Imaging Market - Porter's Five Forces |
3.5 Australia Molecular Imaging Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Australia Molecular Imaging Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.7 Australia Molecular Imaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Australia Molecular Imaging Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Australia Molecular Imaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Australia Molecular Imaging Market Trends |
6 Australia Molecular Imaging Market, By Types |
6.1 Australia Molecular Imaging Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Australia Molecular Imaging Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Australia Molecular Imaging Market Revenues & Volume, By Magnetic Resonance Spectroscopy, 2021- 2031F |
6.1.4 Australia Molecular Imaging Market Revenues & Volume, By Optical Imaging, 2021- 2031F |
6.1.5 Australia Molecular Imaging Market Revenues & Volume, By Molecular Ultrasound Imaging, 2021- 2031F |
6.2 Australia Molecular Imaging Market, By Device Type |
6.2.1 Overview and Analysis |
6.2.2 Australia Molecular Imaging Market Revenues & Volume, By Positron Emission Tomography (PET) Scanner, 2021- 2031F |
6.2.3 Australia Molecular Imaging Market Revenues & Volume, By Single Photon Emission Computed Tomography (SPECT) Scanner, 2021- 2031F |
6.2.4 Australia Molecular Imaging Market Revenues & Volume, By Gamma Camera, Nuclear Magnetic Resonance (NMR) Spectrometer, 2021- 2031F |
6.2.5 Australia Molecular Imaging Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Australia Molecular Imaging Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Australia Molecular Imaging Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.3.3 Australia Molecular Imaging Market Revenues & Volume, By Neurology, 2021- 2031F |
6.3.4 Australia Molecular Imaging Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.3.5 Australia Molecular Imaging Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.6 Australia Molecular Imaging Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Australia Molecular Imaging Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Australia Molecular Imaging Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia Molecular Imaging Market Revenues & Volume, By Diagnostic Imaging Centers, 2021- 2031F |
6.4.4 Australia Molecular Imaging Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.4.5 Australia Molecular Imaging Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Molecular Imaging Market Import-Export Trade Statistics |
7.1 Australia Molecular Imaging Market Export to Major Countries |
7.2 Australia Molecular Imaging Market Imports from Major Countries |
8 Australia Molecular Imaging Market Key Performance Indicators |
9 Australia Molecular Imaging Market - Opportunity Assessment |
9.1 Australia Molecular Imaging Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Australia Molecular Imaging Market Opportunity Assessment, By Device Type, 2021 & 2031F |
9.3 Australia Molecular Imaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Australia Molecular Imaging Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Australia Molecular Imaging Market - Competitive Landscape |
10.1 Australia Molecular Imaging Market Revenue Share, By Companies, 2024 |
10.2 Australia Molecular Imaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |